Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Koch's Disease”

1,665 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,665 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05547464
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 497
Early research (Phase 1)Study completedNCT06224608
What this trial is testing

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 60
Early research (Phase 1)Study completedNCT06438978
What this trial is testing

Tuberculosis Vaccine in Healthy Indian Adults

Who this might be right for
Tuberculosis
Bharat Biotech International Limited 30
Large-scale testing (Phase 3)Ended earlyNCT04453293
What this trial is testing

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

Who this might be right for
Tuberculosis Infection
Henry M. Jackson Foundation for the Advancement of Military Medicine 16
Not applicableLooking for participantsNCT06585358
What this trial is testing

DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Karolinska Institutet 30
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT04717908
What this trial is testing

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 89
Large-scale testing (Phase 3)UnknownNCT05376189
What this trial is testing

Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis

Who this might be right for
SpondylitisTuberculosis
Hasanuddin University 37
Large-scale testing (Phase 3)Study completedNCT03947138
What this trial is testing

GC3107(BCG Vaccine) in Healthy Infants

Who this might be right for
BCG Vaccination ReactionTuberculosis
Green Cross Corporation 750
Not applicableStudy completedNCT03559582
What this trial is testing

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Who this might be right for
Tuberculosis
University of Virginia 478
Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Not applicableActive Not RecruitingNCT04567368
What this trial is testing

TB-CAPT MTB/XDR Study

Who this might be right for
TuberculosisResistance BacterialDiagnoses Disease
Foundation for Innovative New Diagnostics, Switzerland 753
Not applicableLooking for participantsNCT07125274
What this trial is testing

Sputum-free Diagnostis of TB

Who this might be right for
Tuberculosis
Research Center Borstel 100
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableWithdrawnNCT03277742
What this trial is testing

Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz

Who this might be right for
Pulmonary TuberculosisDiabetes Mellitus, Type 2
Instituto Nacional de Salud Publica, Mexico
Early research (Phase 1)UnknownNCT03199690
What this trial is testing

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Who this might be right for
HIV-1-infectionTuberculosis
St. Stephens Clinical Research 16
Not applicableLooking for participantsNCT05426720
What this trial is testing

Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

Who this might be right for
Pulmonary TB
Peking University Third Hospital 400
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Next Page